| Application no. and date | 17754240.4 (espacenet) (Federated) (European Patent Register), 20170804 | | Patent/reg. no. and date | DK/EP 3493830, 20251203 | | Publication date | 20190612 | | Priority no. and date | US 201662371030 P, 20160804 | | EP pub. no. and date |
EP 3493830 20190612 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome
Chuo-ku
Osaka-shi, Osaka, JP | | Applicant ref. no. | | | Inventor | SCHEIFLINGER, Friedrich, Michelbeuerngasse 4/17
1090 Vienna, AT,
EWENSTEIN, Bruce, 15 Claflin Path
Brookline, MA 02445, US,
MAJER, Bernhard, Colloredogasse 25A
1180 Vienna, AT,
ROSSATO, Paolo, Liechtensteinstrasse 3
1090 Vienna, AT,
TURECEK, Marietta, Frauenwald 2
3001 Mauerbach, AT,
GOLDSTEIN, Brahm, 2694 Dorado Court
Thousand Oaks,
California 91362, US | | Representative | | | Opponent | | | IPC Class | A61K 38/48 (2006.01) , A61P 11/00 (2006.01) , A61P 25/04 (2006.01) , A61P 7/02 (2006.01) , A61P 9/00 (2006.01) | | Title | USE OF ADAMTS13 FOR TREATING, AMELIORATING AND/OR PREVENTING VASO-OCCLUSIVE CRISIS IN SICKLE CELL DISEASE, ACUTE LUNG INJURY AND/OR ACUTE RESPIRATORY DISTRESS SYNDROME | | Int. application no. | US2017045573 | | Int. publication no. | WO2018027169 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
